Camrelizumab vs Placebo in Patients With Triple-Negative Breast Cancer. Fan L, Shao ZM. JAMA 2025 Apr 23. doi: 10.1001/jama.2025.1294.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fan L, Shao ZM. Camrelizumab vs Placebo in Patients With Triple-Negative Breast Cancer. JAMA 2025 Apr 23. doi: 10.1001/jama.2025.1294.
PMID: 40266589